姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Li,Zhong-Xun | Chairman | 7.28% | |
Shen,Wen-Chang | Director | 10.28% | |
Bai,You-Qin | Director | 4.44% | |
Lin,Guan-Zhen | Director | 0.00% | |
Gao,Han-Mou | Independent Director | 0.00% | |
Pan,Hong-Mou | Independent Director | 0.00% | |
Lai,Jia-Yi | Independent Director | 0.00% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 168,328 | 280,663 | 381,004 |
Operating cost | 119,383 | 224,338 | 337,855 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 48,945 | 56,325 | 43,149 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 48,945 | 56,325 | 43,149 |
Operating expenses | 41,911 | 81,990 | 94,645 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 7,034 | -25,665 | -51,496 |
Non-operating income and expenses | 563 | -4,096 | 4,234 |
Net profit (loss) before tax | 7,597 | -29,761 | -47,262 |
Income tax expense (benefits) | 1,755 | -4,824 | -7,493 |
Net profit (loss) of ongoing business for the current period | 5,842 | -24,937 | -39,769 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 5,842 | -24,937 | -39,769 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 5,842 | -24,937 | -39,769 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | 0 | -1 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 250,998 | 272,512 | 271,871 |
Non-current asset | 641,004 | 644,077 | 656,935 |
Total asset | 892,002 | 916,589 | 928,806 |
Current liability | 282,256 | 302,962 | 268,666 |
Non-current liability | 126,577 | 136,300 | 157,876 |
Total liability | 408,833 | 439,262 | 426,542 |
share capital | 321,335 | 321,335 | 321,335 |
Equity - secruity token | - | - | - |
capital reserve | 135,453 | 135,453 | 135,453 |
retained earning | 26,381 | 20,539 | 45,476 |
Other equity | 0 | 0 | 0 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 483,169 | 477,327 | 502,264 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 15 | 14 | 15 |